Eaton Vance Management Immunovant, Inc. Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$13.08 - $49.6 $3.57 Million - $13.5 Million
-273,138 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$36.36 - $52.71 $33,851 - $49,073
-931 Reduced 0.34%
273,138 $12.6 Million
Q3 2020

Nov 13, 2020
BUY
$22.61 - $38.9 $6.2 Million - $10.7 Million
274,069 New
274,069 $9.64 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email